PratiÅ›yaÌ„ya is one among Nāsāroga. Untreated or improperly treated PratiÅ›yaÌ„ya leads to chronic condition known as DusÌ£tÌ£a PratiÅ›yaÌ„ya. It is a TridosÌ£aja VyaÌ„dhi and is closely resembling to Rhinosinusitis of conventional medicine. Characteristic features of DusÌ£tÌ£a PratiÅ›yaÌ„ya are NaÌ„saÌ„sraÌ„va (running nose), GhraÌ„noparodha (nasal obstruction or congestion), Åširorujā (headache), Åširogaurava (heaviness of head), KaÌ„sa (coughing), KaphotkleÅ›a (expectoration), Svarabheda (hoarseness of voice).As DusÌ£tÌ£a PratiÅ›yaÌ„ya is a chronic condition of Doá¹£a accumulated particularly in NaÌ„saÌ„ and ÅširahÌ£a, which occurs mainly due to Saṅga type of SrotodusÌ£tÌ£i.In Ayurveda nose is considered as gate way of head, Nasya is the therapeutic procedure in which the medicaments are administered through nasal route which will act on NaÌ„saÌ„ and Åširogata Doá¹£a DusÌ£tÌ£i. Sirovirecana type of Nasyas are preferred to eliminate the accumulated Doṣās from Siraha Pradesa. Nasya with SÌ£adÌ£bindu Taila and KatÌ£phala CuÌ„rnÌ£a cause Åširovirecana and hence are mentioned in the treatment of PratiÅ›yaÌ„ya in classical Ayurveda texts.Patient that fulfill the inclusion criteria of rhinosinusitis will be selected from O.P.D and I.P.D of Post Graduate Departments of KaÌ„yacikitsaÌ„, PañcaKarma and Department of ÅšaÌ„laÌ„kya Tantra, P.D. Patel Ayurvedic Hospital,Nadiad for the present study irrespective of age, sex, caste, religion etc.Both A and B group will be treated with Pathyādi kvātha 40 ml/twice a day (empty stomach) Sitopalādi CuÌ„rnÌ£a-2gm twice a day with Madhu in oral medicaments. Group A will be treated with SÌ£adÌ£bindu Taila Nasya -6 drops in each nostril and Group B will be treated by Katphala CuÌ„rnÌ£a Nasya- one pinch in each nostril followed by UÌ„rdhvajatrugata Abhyaṅga with NaÌ„raÌ„yanÌ£a Taila (Daily) and UÌ„rdhvajatrugata Svedana with hot water bag daily.The total duration of treatment will be 21 days. Patients will be followed up every 15 days up to 1 month after completion of the treatment for observation of further changes in signs and symptoms during follow-up period.